Applications open for Editor-in-Chief, Translational and Clinical Neuroendocrinology, Journal of Neuroendocrinology
Applications are invited for the position of Editor-in-Chief of the Translational and Clinical Neuroendocrinology strand of the Journal of Neuroendocrinology.
We are seeking applications for this leadership position with the prestigious Journal of Neuroendocrinology (JNE), which is owned by the British Society for Neuroendocrinology (BSN) and has wide international membership.
JNE is an international journal for the publication of original research papers and reviews across the full breadth of neuroendocrinology. It is well-established, having been in publication since 1989. The readership and importance of the journal has grown steadily, and it has a worldwide base of subscribers, authors and readers.
The journal is published for BSN by Wiley under a contract running until 2028. Wiley provide the administrative support for peer review, using ScholarOne and a dedicated staff team, as well as carrying out all production, online publishing, and sales and marketing functions.
JNE has been edited by Professor Julian Mercer (Aberdeen, UK) since 2014, and since 2020 Professor Bob Millar (Pretoria, South Africa), who was appointed as EiC of the Translational and Clinical Neuroendocrinology (TCN) strand when the journal was expanded to include translational and clinical aspects. Professor Mercer is Editor-in-Chief (EiC) of the Fundamental and Mechanistic (FMN) strand, and will be handing over responsibilities to Professor Mike Lehman (Kent State University, OH) as the new EiC from January 2024.
An exciting time to join the Journal
The growth of the journal’s remit and extension to cover clinical aspects, along with moves toward Open Access (OA), make this an exciting time to become involved in the ongoing global development of a premier journal within the field of neuroendocrinology.
The successful candidate will be a recognised leader within the international neuroendocrine community and will be expected to hold an impressive track record as a published author along with senior editorial experience, as well as leadership experience in academia and/or clinical service. Above all, the successful candidate must be passionate about JNE and demonstrate a clear vision for its future growth and development as journals move towards full OA publication.
The successful candidate will have the opportunity to be involved in the strategic development of JNE from the appointment date. The formal handover date will be 1 January 2025, but it is anticipated that the incoming editor will begin handling new submissions and commissioning material in advance of that date.
How to apply
Those interested in applying may contact the BSN President, Neil Evans (firstname.lastname@example.org), and/or the Journal Secretary, Dave Grattan (email@example.com), and/or the BSN CEO, Sue Thorn (firstname.lastname@example.org), in confidence if they wish.
The BSN welcomes applicants from all backgrounds. The Editor-in-Chief of the TCN strand can be based at any international location and would be required to join the BSN if not already a member. A modest financial support package will be available for the successful candidate.
Applications should include a curriculum vitae and an accompanying letter outlining the skills, experience and knowledge you would bring to this position and a summary of your vision for the TCN strand of JNE, especially how you see it flourishing as journals move from subscriptions to Open Access.
Applications will be shortlisted after the closing date, with interview dates TBC. Please send your application, in confidence, to the BSN Journal Secretary, Professor Dave Grattan (email@example.com). Applications should arrive no later than 5 January 2024 at 17.00 GMT.
Journal of Neuroendocrinology is a global, non-profit journal covering all aspects of neuroendocrine research. Providing a single home for high quality research reports and review articles from across the discipline, the Journal has two strands, Fundamental and Mechanistic Neuroendocrinology (FMN), and Translational and Clinical Neuroendocrinology (TCN). JNE is owned by the British Society for Neuroendocrinology and is also the official journal of the European Neuroendocrine Tumor Society (ENETS), the Pan American Neuroendocrinology Society (PANS), the European Neuroendocrine Association (ENEA), the International Neuroendocrine Federation (INF), Hypothalamic Neuroscience and Neuroendocrinology Australasia (HNNA), and the International Regulatory Peptide Society (IRPS).
The FMN strand of Journal of Neuroendocrinology publishes the latest ideas in classical, molecular and mechanistic neuroendocrinology and its expanding interface with the regulation of behavioural, cognitive, developmental, degenerative and metabolic processes.
The TCN strand of Journal of Neuroendocrinology publishes original translational and clinical neuroendocrinology and neuroendocrine oncology articles as well as consensus guidelines on the diagnosis and treatment of neuroendocrine disorders. It works closely with ENETS, ENEA, PANS and HNNA to publish special focus issues and consensus and guideline publications.
The combination of the FMN and TCN strands makes JNE the most comprehensive journal in the field with the full spectrum of basic and clinical research.
About the BSN
The BSN (www.neuroendo.org.uk) promotes research into the interactions between the endocrine and nervous systems that control many important body processes. It supports neuroendocrinology worldwide and has members in over 30 countries. BSN’s main activities are JNE, an annual conference, support of the quadrennial International Congress of Neuroendocrinology, and a substantial grants programme.